Jon E. Angell

Array ( [id] => 6174176 [patent_doc_number] => 20110177054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'USE OF ENDO-LYSOSOMAL SYSTEM AND SECRETED VESICLES (EXOSOME-LIKE) IN TREATMENTS AND DIAGNOSTICS BASED ON SMALL RNA AND EXPERIMENTAL STUDY OF SMALL RNA' [patent_app_type] => utility [patent_app_number] => 12/996287 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 28998 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177054.pdf [firstpage_image] =>[orig_patent_app_number] => 12996287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561960 [patent_doc_number] => 20110275793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Chemical RNA Synthesis Method' [patent_app_type] => utility [patent_app_number] => 12/995001 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13888 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275793.pdf [firstpage_image] =>[orig_patent_app_number] => 12995001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7491693 [patent_doc_number] => 08030475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Inhibitors of retroviral reverse transcriptase' [patent_app_type] => utility [patent_app_number] => 12/471166 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 20 [patent_no_of_words] => 17251 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030475.pdf [firstpage_image] =>[orig_patent_app_number] => 12471166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501961 [patent_doc_number] => 20110263677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'GOS2 MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA' [patent_app_type] => utility [patent_app_number] => 12/990995 [patent_app_country] => US [patent_app_date] => 2009-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5678 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263677.pdf [firstpage_image] =>[orig_patent_app_number] => 12990995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944972 [patent_doc_number] => 20110105592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'ANTI-SENSE MICRORNA EXPRESSION VECTORS' [patent_app_type] => utility [patent_app_number] => 12/989627 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9965 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105592.pdf [firstpage_image] =>[orig_patent_app_number] => 12989627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6547321 [patent_doc_number] => 20100016406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Antisense RNA for Treating Cancer and Inhibition of Metastasis and Vectors for Antisense Sequestration' [patent_app_type] => utility [patent_app_number] => 12/430737 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 24100 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016406.pdf [firstpage_image] =>[orig_patent_app_number] => 12430737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316568 [patent_doc_number] => 20090281166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Treatment of Cancer by Inhibition of HSP27' [patent_app_type] => utility [patent_app_number] => 12/423359 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5286 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281166.pdf [firstpage_image] =>[orig_patent_app_number] => 12423359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320081 [patent_doc_number] => 20100113284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'SMALL INTERFERING RNA (SIRNA) TARGET SITE BLOCKING OLIGOS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/418076 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16179 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113284.pdf [firstpage_image] =>[orig_patent_app_number] => 12418076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10567378 [patent_doc_number] => 09290534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside' [patent_app_type] => utility [patent_app_number] => 12/934498 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26821 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12934498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386411 [patent_doc_number] => 20090227656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'METHODS FOR USING MODULATORS OF PROLINE-RICH TYROSINE KINASE 2' [patent_app_type] => utility [patent_app_number] => 12/403342 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 14294 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227656.pdf [firstpage_image] =>[orig_patent_app_number] => 12403342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159382 [patent_doc_number] => 20110158955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'METHOD FOR PRODUCING CELLS HAVING CHARACTERISTIC OF HEMATOPOIETIC STEM CELLS/PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 12/922037 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11740 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20110158955.pdf [firstpage_image] =>[orig_patent_app_number] => 12922037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304264 [patent_doc_number] => 20090298916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Pharmaceutical compositions for treatment of microRNA related diseases' [patent_app_type] => utility [patent_app_number] => 12/400625 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24446 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298916.pdf [firstpage_image] =>[orig_patent_app_number] => 12400625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725543 [patent_doc_number] => 08404659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Pharmaceutical compositions for treatment of MicroRNA related diseases' [patent_app_type] => utility [patent_app_number] => 12/921339 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 4 [patent_no_of_words] => 24412 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12921339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458774 [patent_doc_number] => 20090258926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Methods and Compositions for Delivering siRNA into Mammalian Cells' [patent_app_type] => utility [patent_app_number] => 12/390913 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8138 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258926.pdf [firstpage_image] =>[orig_patent_app_number] => 12390913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609377 [patent_doc_number] => 07994150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Micro-RNAs that modulate smooth muscle proliferation and differentiation and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/391028 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 23726 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994150.pdf [firstpage_image] =>[orig_patent_app_number] => 12391028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501661 [patent_doc_number] => 20090162349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'METHOD FOR PREVENTION OR TREATMENT OF DISEASES OR DISORDERS RELATED TO EXCESSIVE FORMATION OF VASCULAR TISSUE OR BLOOD VESSELS' [patent_app_type] => utility [patent_app_number] => 12/388894 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7811 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162349.pdf [firstpage_image] =>[orig_patent_app_number] => 12388894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458779 [patent_doc_number] => 20090258931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'CHIMERIC OLIGOMERIC COMPOUNDS COMPRISING ALTERNATING REGIONS OF NORTHERN AND SOUTHERN CONFORMATIONAL GEOMETRY' [patent_app_type] => utility [patent_app_number] => 12/388856 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 66375 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258931.pdf [firstpage_image] =>[orig_patent_app_number] => 12388856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7966231 [patent_doc_number] => 07939506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Treating hepatoma by inhibiting expression of gankyrin' [patent_app_type] => utility [patent_app_number] => 12/372899 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 19279 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939506.pdf [firstpage_image] =>[orig_patent_app_number] => 12372899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496477 [patent_doc_number] => 20090264505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR RNAI MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMALS' [patent_app_type] => utility [patent_app_number] => 12/368082 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18212 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264505.pdf [firstpage_image] =>[orig_patent_app_number] => 12368082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6121432 [patent_doc_number] => 20110077283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/865281 [patent_app_country] => US [patent_app_date] => 2009-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23372 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077283.pdf [firstpage_image] =>[orig_patent_app_number] => 12865281 [rel_patent_id] =>[rel_patent_doc_number] =>)